Abstract
Nearly one-third of the world’s population has hypertension. The human and societal impact of hypertension is enormous. Primary hypertension accounts for 95 % of cases of hypertension in adults. The pathogenesis of primary hypertension is complex. The kidney and the sympathetic nervous system play important roles in the development and maintenance of hypertension. This review discusses their respective roles, the interaction between the two, implications of sympathetic overactivity in kidney disease and therapeutic interventions that have been developed on the basis of this knowledge, especially modulation of the sympathetic nervous system.
Similar content being viewed by others
References
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217–223
Norwood VF (2002) Hypertension. Pediatr Rev 23:197–208
Din-Dzietham R, Liu Y, Bielo MV, Shamsa F (2007) High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation 116:1488–1496
World Health Organisation (2011) Global status report on non-communicable disease 2010
Carretero OA, Oparil S (2001) Essential hypertension. Part I: definition and etiology. Circulation 101:329–335
Wyszyńska T, Cichocka E, Wieteska-Klimczak A, Jobs K, Januszewicz P (1992) A single pediatric center experience with 1025 children with hypertension. Acta Paediatr 81:244–246
Flynn JT (2001) Evaluation and management of hypertension in childhood. Prog Pediatr Cardiol 12:177–188
Oparil S, Zaman MA, Calhoun DA (2003) Pathogenesis of hypertension. Ann Intern Med 139:761–776
Bright R (1836) Tabular view of the morbid appearances in 100 cases connected with albuminous urine: With observations. Guy’s Hospital Resp 1:380
Mohamed FA (1877) On the sphygmomanometric evidence of arteriocapillary sclerosis. Trans Path Soc 28:394–401
Klahr S (1989) The kidney in hypertension—villain and victim. N Eng J Med 320:731–733
Hall JE, Brands MW, Shek EW (1996) Central role of the kidney and abnormal volume control in hypertension. J Human Hypertens 10:633–639
Dahl LK, Heine M (1975) Primary role of renal homographs in setting chronic blood pressure level in rats. Circ Res 36:692–696
Rettig R, Folberth CG, Stauss H, Kopf D, Waldherr R, Baldauf G, Unger T (1990) Hypertension in rats induced by renal grafts from renovascular hypertension donors. Hypertens 15:429–435
Bianchi G, Fox U, Di Francesco GF, Bardi U, Radice M (1973) The hypertensive role of the kidney in spontaneously hypertensive rats. Clin Sci 45:135S–139S
Rettig R, Bandelow N, Patschan O, Kuttler B, Frey B, Uber A (1996) The importance of the kidney in primary hypertension: insights from cross transplantation. J Human Hypertens 10:641–644
Koomans HA, Joles JA, Rabelink TJ (1996) Hypertension and the kidney: culprit and victim. Nephrol Dial Transplant 11:1961–1966
Guyton AC (1990) Long-term arterial pressure control: an analysis from animal experiments and computer and graphic models. Am J Physiol 259:R865–R877
Hall JE, Mizelle HL, Hildebrandt DA, Brands MW (1990) Abnormal pressure natriuresis: a cause or consequence of hypertension? Hypertension 15:547–559
Coleman TG, Cowley AW, Guyton AC (1975) Experimental hypertension and the long-term control of arterial pressure. In: Guyton AC, Jones CE (eds) MTP international review of science, cardiovascular physiology, vol 1. University Park Press, Baltimore, pp 259–298
Hall JE (1991) Renal function in one kidney, one-clip hypertension and low renin essential hypertension. Am J Hypertens 4:523s–533s
Curtis JJ, Luke RG, Dustan HP, Kashgarian N, Whelchel JD, Jones P, Diethelm AD (1983) Remission of essential hypertension after renal transplantation. N Engl J Med 309:1009–1015
Grim CE, Luft FC, Miller JZ, Brown PL, Gannon MA, Weinberger MH (1979) Effect of sodium loading and depletion on normotensive first-degree relatives of hypertensives. J Lab Clin M 94:964–971
Widgren H, Herlitz BR, Hedner T, Berglund G, Wikstran Jonsson O, Anderson OK (1991) Blunted renal sodium excretion during acute saline loading in normotensive men with positive family history of hypertension. Am J Hypertens 4:570–578
Pusterela C, Beretta-Piccoli C, Städler O, Weidmann Favre L, Valotton M (1986) Blood pressure regulation on low and high sodium diets in normotensive members of normotensive or hypertensive families. J Hypertens 4:S310–S313
Skimkets RA, Warnock DG, Bositis CM, Nelson Williams C, Hansson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier B, Lifton RP (1994) Liddle syndrome—heritable human hypertension caused by mutations in the beta-subunit of the epithelial sodium channel. Cell 79:407–414
Mune T, Rogerson FM, Nikkilá H, Agarwal AK, White PC (1995) Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nature Genet 10:394–399
Bianchi G, Baer PG, Fox U, Duzzi L, Pagetti D, Giovannetti AM (1975) Changes in renin, water balance and sodium during development of hypertension in genetically hypertensive rats. Circ Res 37(suppl 1):153–161
Bierwaltes WH, Arenshorst WJ, Kremmer PJ (1982) Electrolyte and water balance in young hypertensive rats. Hypertension 4:908–915
Woolfson RG, de Wardener HE (1996) Primary renal abnormalities in hereditary hypertension. Kidney Inter 50:717–731
Hollenberg NK, Williams GH, Adams DF (1981) Essential hypertension: abnormal renal vascular and endocrine response to psychological stimulus. Hypertension 3:11–17
Uneda S, Fujishima S, Fujiki Y, Tochikubo O, Oda H, Ashahina Kaneko Y (1984) Renal haemodynamics and the renin angiotensin system in adolescents genetically predisposed to essential hypertension. J Hypertens 2:S437–S439
Roman RJ, Kaldunski M (1988) Pressure natriuresis and cortical and papillary blood flow in spontaneously hypertensive rats. Hypertension 11:657–663
Roman RJ, Kaldunski M (1991) Pressure natriuresis and cortical and papillary blood flow in inbred Dahl rats. Am J Phsiol 255:R756–R759
Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR (1992) Molecular basis of human hypertension. Role of angiotensinogen. Cell 71:169–180
Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM (1994) Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 93:1285–1287
Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJ (1994) Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330:1629–1633
Lüscher TF, Boulanger CF, Yang Z, Noll G, Dohi Y (1993) Interactions between endothelium-derived relaxing and constricting factors in health and cardiovascular disease. Circulation 87:V36–V44
Levine GN, Keaney JF, Vita JA (1995) Cholesterol reduction in cardiovascular disease. N Engl J Med 332:512–521
Chen PY, Sanders PW (1991) L-arginine abrogates salt sensitive hypertension in Dahl/Rapp rats. J Clin Invest 88:1559–1567
Lüscher TF, Vanhoutte PM (1986) Endothelium derived contractions to acetylchol;ine in the aorta of the spontaneously hypertensive rats. Hypertension 8:344–348
Zhang BL, Liu KL, Benzoni D, Sassard J (1993) Nitric oxide and eicosanoid interactions in kidneys of Lyon hypertensive rats. J Hypertens 5:136–137
Brenner BM, Garcia DL, Anderson S (1988) Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1:335–347
Barker DJ (1992) The fetal origins of adult hypertension. J Hypertens Suppl 10:S39–S44
Keller J, Zimmer G, Mall G, Ritz E, Amann K (2003) Nephron number in patients with primary hypertension. N Engl J Med 348:101–118
Zandi-Nejad K, Luyckx VA, Brenner BM (2006) Adult hypertension and kidney disease: the role of fetal programming. Hypertension 47:502–508
Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B (2002) Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 346:913–923
Ceisus AAC De Re Medicina (1935–1938) 3 vols, (transl: Spencer W). London: Heinemann
Mark AL (1996) The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens Suppl 14:S159–S165
Esler M, Lambert G, Brunner-La Rocca HP, Vaddadi G, Kaye D (2003) Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand 177:275–284
Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G (1998) Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 31:64–67
Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Ishii M (1989) Age-related changes in muscle sympathetic nerve activity in essential hypertension. Hypertension 13:870–877
Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S (1994) Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 90:928–936
Grassi G, Giannattasio C, Failla M, Pesenti A, Peretti G, Marinoni E et al (1995) Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension 26:348–354
Kim JR, Kiefe CI, Liu K, Williams OD, Jacobs DR Jr, Oberman A (1999) Heart rate and subsequent blood pressure in young adults: the CARDIA study. Hypertension 33:640–646
Esler M (2000) The sympathetic system and hypertension. Am J Hypertens 13:99S–105S
Chapleau MW, Hajduczok G, Abboud FM (1988) Mechanisms of resetting of arterial baroreceptors: an overview. Am J Med Sci 295:327–334
Guo GB, Thames MD, Abboud FM (1983) Arterial baroreflexes in renal hypertensive rabbits. Selectivity and redundancy of baroreceptor influence on heart rate, vascular resistance, and lumbar sympathetic nerve activity. Circ Res 53:223–234
Xie PL, Chapleau MW, McDowell TS, Hajduczok G, Abboud FM (1990) Mechanism of decreased baroreceptor activity in chronic hypertensive rabbits. Role of endogenous prostanoids. J Clin Invest 86:625–630
Sainio K, Suvanto P, Davies J, Wartiovaara J, Wartiovaara K, Saarma M, Arumäe U, Meng X, Lindahl M, Pachnis V, Sariola H (1997) Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 124:4077–4087
Cullen-McEwen LA, Kett MM, Dowling J, Anderson WP, Bertram JF (2003) Nephron number, renal function, and arterial pressure in aged GDNF heterozygous mice. Hypertension 41:335–340
Gattone VH, Evan AP, Overhage JM, Severs WB (1990) Developing renal innervation in the spontaneously hypertensive rat: evidence for a role of the sympathetic nervous system in renal damage. J Hypertens 8:423–428
Head RJ (1989) Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels 26:1–20
Grisk O, Rose H-J, Lorenz G, Rettig R (2002) Sympathetic—renal interaction in chronic arterial pressure control. Am J Physiol Regul Integr Comp Physiol 283:R441–R450
Scislo TJ, Augustyniak RA, O’Leary DS (1998) Differential arterial baroreflex regulation of renal, lumbar, and adrenal sympathetic nerve activity in the rat. Am J Physiol 275:R995–R1002
Johansson M, Rundqvist B, Petersson M, Lambert G, Friberg P (2003) Regional norepinephrine spillover in response to angiotensin-converting enzyme inhibition in healthy subjects. J Hypertens 21:1371–1375
Abboud FM (1974) Effects of sodium, angiotensin, and steroids on vascular reactivity in man. Fed Proc 33:143–149
Li Z, Mao HZ, Abboud FM, Chapleau MW (1996) Oxygen-derived free radicals contribute to baroreceptor dysfunction in atherosclerotic rabbits. Circ Res 79:802–811
Hollenberg NK, Adams DF, Solomon H, Chenitz WR, Burger BM, Abrams HL, Merrill JP (1975) Renal vascular tone in essential and secondary hypertension: hemodynamic and angiographic responses to vasodilators. Medicine (Baltimore) 54:29–44
Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G (1990) Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 70:963–985
DiBona GF, Sawin LL (1999) Functional significance of the pattern of renal sympathetic nerve activation. Am J Physiol 277:R346–R353
DiBona GF, Kopp UC (1995) Neural control of renal function: role in human hypertension. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis, and management, 2nd edn. Raven Pr, New York, pp 1349–1358
DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77:75–197
Light KC (2000) Environmental and psychosocial stress in hypertension onset and progression. In: Oparil S, Weber MA (eds) Hypertension: a companion to Brenner and Rector’s the kidney. WB Saunders, Philadelphia, pp 59–70
Hendley ED, Ohlsson WG (1991) Two new inbred rat strains derived from SHR: WKHA, hyperactive, and WKHT, hypertensive, rats. Am J Physiol 261:H583–H589
DiBona GF, Jones SY, Sawin LL (1996) Renal sympathetic neural mechanisms as intermediate phenotype in spontaneously hypertensive rats. Hypertension 27:626–630
Lee RMKW, Borkowski KR, Leenen FHH, Tsoporis J, Coughlin M (1991) Combined effect of neonatal sympathectomy and adrenal demedullation on blood pressure and vascular changes in spontaneously hypertensive rats. Circ Res 69:714–721
Law CM, Sheill AW (1996) Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. J Hypertens 14:935–941
Weitz G, Deckert P, Heindl S, Struck J, Perras B, Dodt C (2003) Evidence for lower sympathetic nerve activity in young adults with low birth weight. J Hypertens 21:943–950
Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I (1997) The hypertension of autonomic failure and its treatment. Hypertension 30:1062–1067
Esler M, Jennings G, Korner P, Blombery P, Sacharias N, Leonard P (1984) Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol 247:E21–E28
Esler M, Jennings G, Leonard P, Sacharias N, Burke F, Johns J, Blombery P (1984) Contribution of individual organs to total noradrenaline release in humans. Acta Physiol Scand Suppl 527:11–16
Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG (1979) Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 59:919–957
Cuche JL, PrinseauJ SF (1986) Plasma free, sulfo- and glucuro-conjugated catecholamines in uremic patients. Kidney Int 30:566–572
Elias AN, Vaziri ND, Maksy M (1985) Plasma norepinephrine, epinephrine, and dopamine levels in end-stage renal disease. Effect of hemodialysis. Arch Intern Med 145:1013–1015
Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, Dell’Oro R, Mancia G (2011) Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 57:846–851
Klein IHHT, Ligtenberg G, Neumann J, Oey PL, Koomans HA, Blankestijn PJ (2003) Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol 14:3239–3244
Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, Van Huffelen AC, Koomans HA (1999) Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 340:1321–1328
Ye S, Ozgur B, Campese VM (1997) Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 51:722–727
Ye S, Zhong H, Yanamadala V, Campese VM (2002) Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens 15:717–724
Campese VM, Kogosov E (1995) Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 25:878–882
Campese VM, Kogosov E, Koss M (1995) Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis 26:861–865
Converse RL, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG (1992) Sympathetic overactivity in patients with chronic renal failure. New Engl J Med 327:1912–1918
Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH (2002) Sympathetic nerve activity in end-stage renal disease. Circulation 106:1974–1979
Cottone S, Lorito MC, Riccobene R, Nardi E, Mul G, Buscemi S, Geraci C, Guarneri M, Arsena R, Cerasola G (2008) Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 21:175–179
Natarajan SK, Thomas S, Ramamoorthy P, Basivireddy J, Pulimood AB, Ramachandran A, Balasubramanian KA (2006) Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models. J Gastroenterol Hepatol 21:947–957
Schiffrin EL, Lipman ML, Mann JFE (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation 116:85–97
Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura J, Kohno M, Abe Y (2003) Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 41:266–273
Hirooka Y (2011) Oxidative stress in the cardiovascular center has a pivotal role in the sympathetic activation in hypertension. Hypertens Res 34:407–412
Ye S, Zhong H, Yanamadala S, Campese VM (2006) Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension 48:309–315
Park J (2012) Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system. Cardiol Res Pract. doi:10.1155/2012/319432
Grassi G, Seravalle G, Ghiadoni L, Tripepi G, Bruno RM, Mancia G, Zoccali C (2011) Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease. Clin J Am Soc Nephrol 6:2620–2627
Leone A, Moncada S, Vallance P, Calver A, Collier J (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572–575
Mallamaci F, Tripepi G, Maas R, Malatino L, Böger R, Zoccali C (2004) Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. J Am Soc Nephrol 15:435–441
Augustyniak RA, Victor RG, Morgan DA, Zhang W (2006) L-NAME- and ADMA-induced sympathetic neural activation in conscious rats. Am J Physiol Regul Integr Comp Physiol 290:R726–R732
Bergamaschi CT, Campos RR, Lopes OU (1999) Rostral ventrolateral medulla: a source of sympathetic activation in rats subjected to long-termtreatment with L-NAME. Hypertension 34:744–747
Veljković S, Jovanović-Mićić D, Japundžić N, Samardžić R, Beleslin DB (1989) The area postrema and the hypertensive effect of angiotensin. Metab Brain Dis 4:61–65
Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ (2003) Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol 14:425–430
Siddiqi L, Oey PL, Blankestijn PJ (2011) Aliskiren reduces sympathetic nerve activity and blood pressure in chronic disease patients. Nephrol Dial Transplant 26:2930–2934
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med 351:1296–1305
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17:2034–2047
Rich A (2008) Morbidity and mortality. In:USRDS 2008 Annual Data Report. Bethesda, MD: National Institutes of Health, NIDDK, 129–146
Grassi G, Dell’Oro GR, Mancia G (2011) Sympathetic mechanisms, organ damage, and antihypertensive treatment. Curr Hypertens Rep 13:303–308
Dinenno FA, Jones PP, Seals DR, Tanaka H (2000) Age-associated arterial wall thickening is related to elevations in sympathetic activity in healthy humans. Am J Physiol Heart Circ Physiol 278:H1205–H1210
Grassi G (2006) Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertens Res 29:839–847
Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, Esler MD, Lambert GW (2009) Sympathetic activation in chronic renal failure. J Am Soc Nephrol 20:933–939
Esunge PM (1991) From blood pressure to hypertension: the history of research. J R Soc Med 84:621
Freis ED (1990) Origins and development of antihypertensive treatment. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis, and management. Raven, New York, pp 2093–2094
Fries ED (1995) Historical development of antihypertensive treatment. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis, and management. New York, Raven Press, pp 2741–2751
Peet MM (1947) Results of bilateral supradiaphragmatic splanchnicectomy for arterial hypertension. N Engl JMed 236:270–276
Smithwick RH, Thompson JE (1953) Splanchnicectomy for essential hypertension; results in 1,266 cases. J Am Med Assoc 152:1501–1504
Lyons RH, Moe GK, Neligh RM, Hoobler SW, Campbell KN, Berry RL, Rennick BR (1947) The effects of blockade of the autonomic ganglia in man with tetraethylammonium; preliminary observations on its clinical application. Am J Med Sci 213:315–323
Paton WDM, Zaimis EJ (1948) Clinical potentialities of certain bisquaternary salts causing neuromuscular and ganglionic block. Nature 162:810
(1982) Low doses v standard dose of reserpine. A randomized, double-blind, multiclinic trial in patients taking chlorthalidone. J Am Med Assoc 248:2471–2477
Freis ED (1995) Historical development of antihypertensive treatment. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis, and management, 2nd edn. Raven, New York, pp 2741–2751
Oates JA, Gillespie L Jr, Udenfiiend S, Sjoerdsma A (1960) Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine. Science 131:1890–1891
Prichard BN, Gillam PM (1964) Use of propranolol (Inderal) in treatment of hypertension. Br Med J 2:725–732
(1967) Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. J Am Med Assoc 202:1028–1034.
(1970) Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. J Am Med Assoc 213:1143–1152.
Nash DT (1990) Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism. Clin Cardiol 13:764–772
Heran BS, Galm BP, Wright JM (2012) Blood pressure lowering efficacy of alpha blockers for primary hypertension. Cochrane Database Syst Rev 15(8):CD004643. doi:10.1002/14651858.CD004643.pub3
Saxena PR (1992) Interaction between the renin-angiotensin-aldosterone and sympathetic nervous systems. J Cardiovasc Pharmacol 19:S80–S88
Cox SL, Ben A, Story DF, Ziogas J (1995) Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites. Br J Pharmacol 114:1057–1063
Dorward PK, Rudd CD (1991) Influence of brain renin-angiotensin system on renal sympathetic and cardiac baroreflexes in conscious rabbits. Am J Physiol 260:H770–H778
Ajayi AA, Reid JL (1988) Renin-angiotensin modulation of sympathetic reflex function in essential hypertension and in the elderly. Int J Clin Pharmacol Res 8:327–333
Grassi G, Turri C, Dell’Oro R, Stell ML, Bolla GB, Mancia G (1998) Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. J Hypertens 16:1789–1796
Krum H, Lambert E, Windebank E, Campbell DJ, Esler M (2006) Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol 290:H1706–H1712
Zazgornik J, Biesenbach G, Janko O, Gross C, Mair R, Brücke P, Debska-Slizien A, Rutkowski B (1998) Bilateral nephrectomy: the best, but often overlooked, treatment for refractory hypertension in hemodialysis patients. J Am Hypertens 11:1364–1370
Symplicity HTN-1 Investigators (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57:911–917
Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361:932–934
Krum H, Schlaich M, Whitbourn SPA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multi-centre safety and proof of principle cohort study. Lancet 373:1275–1281
Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376:1903–1909
Mohaupt MG, Schmidli J, Luft FC (2007) Management of uncontrollable hypertension with a carotid sinus stimulation device. Hypertension 50:825–828
Lohmeier TE, Irwin ED, Rossing MA, Serdar DJ, Kieval RS (2004) Prolonged activation of the baroreflex produces sustained hypotension. Hypertension 43:306–311
Scheffers IJ, Kroon AA, Tordoir JH, de Leeuw PW (2008) Rheos baroreflex hypertension therapy system to treat resistant hypertension. Expert Rev Med Devices 5:33–39
Lande MB, Flynn JT (2009) Treatment of hypertension in children and adolescents. Pediatr Nephrol 24:1939–1949
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thomas, P., Dasgupta, I. The role of the kidney and the sympathetic nervous system in hypertension. Pediatr Nephrol 30, 549–560 (2015). https://doi.org/10.1007/s00467-014-2789-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-014-2789-4